Scantox は、遺伝子改変および非遺伝子改変の細胞株、グリア細胞、初代ニワトリ、ラットの末梢神経系および中枢神経系ニューロン（異なる発生段階）や器官型脳スライスなどを含む、数々の標準化細胞培養システムを使った in vitro 研究サービスを提供しています。 ご要望に応じて、新しい評価系の開発・バリデーションも行います。
当社の細胞培養システムでは、アルツハイマー病、パーキンソン病、ハンチントン病、虚血、および他の神経変性疾患や希少疾病の疾患関連病変を再現します。 加えて、薬物安全性のアッセイを実行し、セクレターゼ調整薬および阻害剤を試験する複数のシステムも使用できるようにしております。
お客様の研究プログラムをサポートするカスタマイズ戦略の開発をお考えであれば、是非当社にお問い合わせください。
Drug Screening with Specialized Animal Models and Cell Lines
Primary cells and brain slices can be derived from animal models specific to certain diseases that are available at Scantox, providing the ideal complementary tool for in vitro and in vivo screening of drugs.
Commonly used neuroblastoma and neuroglioma cell lines as well as immortalized glial cells are on stock to perform assays with minimal lead time. Scantox is equipped to perform BSL2 research. Treatment of different cell types with viral vectors, siRNA or any other gene therapy approach is therefore feasible.
Our team has many years of experience in the cultivation and treatment of CNS cells, performs a broad range of readouts, and follows standardized protocols for various methods on a regular basis. Moreover, new models and strategies can be developed and validated upon request to support your research goals. We are flexible to customize the experimental setup of off-the-shelf assays to fit your research project and are constantly developing new technologies to provide state-of-the-art research.
Customer Feedback
"I am grateful for all the exceptional work you did for me. More important than the results, which were good, it's the way you work and the efforts you all did to help me to accomplish my goals."
– POSTDOCTORAL RESEARCHER
